LGD-4033 (Ligandrol) is the SARM with the strongest clinical evidence for muscle growth. In a placebo-controlled trial of healthy young men, participants taking just 1 mg per day gained an average of 1.21 kg (about 2.7 pounds) of lean body mass in only 21 days, with gains increasing in a dose-dependent pattern. That said, no SARM is FDA-approved for human use, and all carry real health risks that go well beyond what most online forums discuss.
Understanding what these compounds actually do, how they compare, and what they cost your body is essential before you consider going any further.
How SARMs Build Muscle Differently Than Steroids
SARMs bind to the same androgen receptors that testosterone does, but they’re designed to activate those receptors primarily in muscle and bone tissue while having a weaker effect on organs like the prostate. Traditional anabolic steroids flood every androgen receptor in your body equally, which is why they cause side effects like prostate enlargement, hair loss, and acne. SARMs achieve their selectivity because they change the shape of the androgen receptor in a slightly different way than testosterone does, which alters which genes get switched on in different tissues.
One practical difference: nonsteroidal SARMs aren’t converted into estrogen or into the more potent form of testosterone (DHT) that drives many androgenic side effects. This is why they don’t typically cause the same degree of hair loss or gynecomastia that steroids do. “Selective” doesn’t mean “side-effect free,” though. The selectivity is partial, not absolute, and at higher doses the tissue specificity breaks down.
LGD-4033: The Strongest Evidence for Lean Mass
Ligandrol has the most robust human data of any SARM for muscle growth. In the clinical trial published in The Journals of Gerontology, 76 healthy men aged 21 to 50 were randomized to placebo or one of three doses (0.1, 0.3, or 1.0 mg) daily for 21 days. Lean body mass increased in a clear dose-dependent pattern, with the 1.0 mg group gaining 1.21 kg on average. Fat mass did not change significantly in any group.
A separate case report tracked a 25-year-old man who self-administered 10 mg of LGD-4033 daily for five weeks. His total lean body mass increased by 3.1%, with trunk lean mass up 6.6% and limb lean mass up 4.3%. His total body mass rose 6%, though fat mass also increased by 15.4%, suggesting the caloric surplus he ate during the cycle contributed to fat gain alongside the muscle. Users in bodybuilding communities typically run LGD-4033 for 8 to 12 weeks, though clinical safety data beyond short-duration studies is essentially nonexistent.
Ostarine: A Milder Starting Point
MK-2866 (Ostarine) was originally developed to combat muscle wasting in cancer patients and people with chronic illness. It’s considered less potent than LGD-4033 for outright mass gain but is often favored by people who want to preserve muscle during a calorie deficit. User reports suggest gains of around 5 to 7 pounds over a six-week bulking cycle, though these numbers come from self-reported community data rather than controlled trials.
Ostarine’s reputation as a “beginner” compound comes from its comparatively milder suppression of natural testosterone production. That doesn’t make it harmless. It still activates androgen receptors systemically, and cases of liver injury have been documented with various SARMs regardless of their perceived mildness.
RAD-140 and S-23: Higher Potency, Higher Cost
RAD-140 (Testolone) is popular among experienced users looking for strength and lean mass without the water retention that comes with some steroids. It binds the androgen receptor with high affinity and is frequently compared to LGD-4033 in online communities, though direct head-to-head human trials don’t exist. RAD-140 appears repeatedly in published case reports of liver toxicity, with multiple hospitalized patients showing liver enzyme levels 10 to 50 times above the normal range after cycles lasting anywhere from four weeks to a year.
S-23 sits at the extreme end of the potency spectrum. It binds the androgen receptor extremely tightly (with a binding affinity around 1.7 nanomolar in lab assays), producing a noticeably “harder” and leaner appearance. That same potency is why pharmaceutical researchers originally explored it as a male contraceptive: in animal studies, S-23 consistently shut down sperm production in a dose-dependent manner. The suppression was reversible after stopping in those rodent models, but no human safety data exists. S-23 is widely considered an advanced-only compound because it suppresses natural testosterone production more aggressively than other SARMs.
Risks the Forums Downplay
The FDA has issued direct warnings that SARMs carry risks of heart attack, stroke, serious liver damage, and acute liver failure. These are not theoretical concerns. Published case reports document young, otherwise healthy men developing jaundice, severe fatigue, and dangerously elevated liver enzymes after SARM cycles. In one case, a 22-year-old man using RAD-140 for 16 weeks developed liver enzyme levels over 50 times the upper limit of normal. In another, a 24-year-old on LGD-4033 for nine weeks presented with jaundice, nausea, weight loss, and mild liver enlargement.
The FDA’s full list of reported adverse effects includes:
- Liver injury, ranging from mild enzyme elevation to acute liver failure requiring hospitalization
- Cardiovascular events, including increased risk of heart attack and stroke
- Hormonal disruption, including testicular shrinkage, sexual dysfunction, and infertility
- Psychiatric effects, including psychosis, hallucinations, and sleep disturbances
Beyond the compounds themselves, there’s a purity problem. SARMs are not approved drugs and not legal dietary supplements. Products sold online are manufactured without regulatory oversight, and independent lab testing has repeatedly found that what’s on the label doesn’t match what’s in the bottle. Some products contain no active SARM at all, others contain different compounds entirely, and some are contaminated with substances that carry their own risks.
Testosterone Suppression Is Not Optional
Every SARM suppresses your body’s natural testosterone production to some degree. When you introduce a compound that activates androgen receptors, your brain registers the signal as “androgens are abundant” and dials down its own production. The hypothalamus reduces its signaling hormones, which causes the pituitary to release less LH and FSH, which tells your testes to produce less testosterone and fewer sperm.
The degree of suppression varies by compound and dose. Ostarine at low doses causes moderate suppression that some users recover from without intervention. LGD-4033 at commonly used doses causes more significant drops. S-23 can suppress testosterone and sperm production so thoroughly that it was studied as a contraceptive. The case report of the man using LGD-4033 at 10 mg daily showed measurable hormonal changes within just five weeks.
Post-Cycle Recovery
Most users plan a post-cycle therapy (PCT) phase to help restart natural testosterone production after a SARM cycle. The two most common PCT medications are tamoxifen (typically 20 to 40 mg daily for four weeks) and clomiphene (50 mg daily for the first two weeks, then 25 mg daily for the following two weeks). Both work by blocking estrogen’s feedback signal to the brain, which prompts the pituitary to ramp LH and FSH production back up.
A standard recovery rule: take at least as much time off as your total cycle plus PCT combined. A 12-week cycle followed by 4 weeks of PCT means waiting 16 weeks before starting another cycle. This window allows hormones, liver enzymes, and cardiovascular markers to return to baseline. Skipping this recovery period or running back-to-back cycles compounds the suppression and increases the likelihood of lasting hormonal disruption.
What You’re Actually Choosing Between
If raw lean mass gain is the single metric, LGD-4033 has the best clinical support. If preserving muscle during fat loss is the priority, Ostarine is the more common choice. If maximum hardness and strength are the goal regardless of side effect severity, experienced users gravitate toward RAD-140 or S-23. None of these compounds are approved for human consumption, none have long-term safety data, and the products available for purchase exist in an unregulated gray market where label accuracy is unreliable.
The gains SARMs produce are real but modest compared to anabolic steroids, while the risks, particularly to liver function and hormonal health, overlap significantly with steroid use. For most people, the risk-to-reward ratio lands in an unfavorable place, especially when you factor in the uncertainty of what’s actually in the product you’re taking.